Clinical Trial Update: Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 [Phase 4]

View source ↗

Summary

This is a Phase 4 randomized, open-label trial comparing pegylated interferon alfa-2a with adjusted-dose ribavirin to standard therapy in treatment-naive patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: King Abdulaziz Medical City | Conditions: Chronic Hepatitis C Virus | Phase 4 | Status: COMPLETED